Full name
GALEN LAB SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ W LIKWIDACJI
uses securityreCAPTCHA
72.19.Z - Scientific research and development activities
47.74.Z - Retail sale of medical and orthopedic products
47.99.Z - Retail trade
71.12.Z - Engineering activities and related technical consultancy
72.11.Z - Scientific research and development activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
86.22.Z - Specialist medical practice
86.90.A - Healthcare
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Profit (loss) on sale | -1,2 | -0,8 | 9,8 | 1290,1 |
Gross profit (loss) | -1,2 | -0,8 | 9,8 | 1290,1 |
EBITDA | -1,2 | -0,8 | 9,8 | 1290,1 |
Short time liabilities | 0 | 0,4 | 1,1 | 189,2 |
Other operating costs | 0 | 0 | 0 | 0 |
Equity capital | 16,4 | 15,5 | 24,6 | 58,5 |
Operating profit (EBIT) | -1,2 | -0,8 | 9,8 | 1290,1 |
Assets | 16,4 | 15,9 | 25,7 | 61,5 |
Net profit (loss) | -1,2 | -0,8 | 9,1 | 1205,3 |
Cash | 16,4 | 15,9 | 25,7 | 61,5 |
Liabilities and provisions for liabilities | 0 | 0,4 | 1,1 | 189,2 |
Net income from sale | 0 | 1 | 14 | 1314,1 |
Working assets | 16,4 | 15,9 | 25,7 | 61,5 |
Other income costs | 0 | 0 | 0 | 0 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | -7,4 | -5,3 | 36,9 | 42,2 |
Equity capital to total assets | 100 | 97,7 | 95,8 | -1,9 |
Gross profit margin | -83,1 | 69,9 | 153 | |
EBITDA Margin | -83,1 | 69,9 | 153 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 0 | 136 | 28 | -108 |
Current financial liquidity indicator | 43.11723327636719 | 24.088773727416992 | -19 | |
Net dept to EBITDA | 13.508386611938477 | 19.336729049682617 | -2.624746084213257 | -21,9 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane